Toyota is finally feeling the heat… and not just from other car companies.
This time it’s also from climate change.
The chairman of Toyota made this point recently, saying, “The environment is deteriorating by the day,” and that the company needs to look for ways to change its cars as soon as possible.
Now, Toyota is trying to look 35 years into the future. Although some of us may find that a ridiculous amount of time to gaze into a crystal ball… unless, of course, it involves eliminating the traditional combustion engine.
Even so, with the sensational threat of irreversible damage from pollution making headlines everyday, it seems that Toyota has a new sense of urgency, and it is looking to set challenging goals for the company as a whole.
As you may know, Toyota is trying to stay ahead of the curve with its Prius — the first mass-produced hybrid.
But to differentiate the company’s goals here, Toyota will not be focusing on purely battery-powered cars. Instead, it will be primarily concerned with it’s hydrogen fuel cell vehicle, the Mirai.
Unfortunately for Toyota, Tesla is already ahead of its competitors by boasting its zero-emission EV’s… yet Toyota may still have the advantage.
It should be clear by now that Toyota has a larger market share than Tesla, or of any other manufacturer, for the time being.
That, however, is about to change…
With the upcoming Tesla Model 3 set to be priced around $35,000, other companies are going to have to start getting creative to be able to competitively price their cars to meet new consumer demands.
To continue reading…
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.